Caxton Associates (New York) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$268M |
| 2 |
Amazon
AMZN
|
+$226M |
| 3 |
Boston Scientific
BSX
|
+$55.2M |
| 4 |
PayPal
PYPL
|
+$42.9M |
| 5 |
Adobe
ADBE
|
+$33.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$241M |
| 2 |
Micron Technology
MU
|
+$171M |
| 3 |
Intel
INTC
|
+$163M |
| 4 |
Microsoft
MSFT
|
+$121M |
| 5 |
Apple
AAPL
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 32.16% |
| 2 | Technology | 19.26% |
| 3 | Healthcare | 6% |
| 4 | Financials | 5.81% |
| 5 | Energy | 5.16% |
Similar funds
Caxton Associates (New York)'s Q3 2024 Portfolio in Review
As of Q3 2024, Caxton Associates (New York) held 673 positions worth $2.67B, down 8.7% from $2.93B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Caxton Associates (New York) withdrew a net $501M in Q3 2024, closing 161 positions and reducing 162 holdings. Its most notable exit was Micron Technology, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 32% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Caxton Associates (New York) opened a new position in Boston Scientific worth $58.7M.
- Caxton Associates (New York)'s largest Q3 2024 buy was Boston Scientific: 700,000 shares worth $58.7M.
- Caxton Associates (New York) added most to Tesla in Q3 2024, an estimated $268M increase.
- Caxton Associates (New York)'s biggest Q3 2024 reduction was Citigroup, cutting an estimated $241M.
- Caxton Associates (New York) fully exited Micron Technology in Q3 2024, selling an estimated $171M.
- Caxton Associates (New York)'s ten largest holdings make up 64% of its $2.67B portfolio in Q3 2024.
- Caxton Associates (New York) opened 208 new positions and closed 161 in Q3 2024.
- Caxton Associates (New York)'s portfolio value fell 8.7% quarter-over-quarter to $2.67B.
Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.